{
  "meta": {
    "title": "Mood_Disorders_Bipolar_And_Related_Disorders",
    "url": "https://brainandscalpel.vercel.app/mood-disorders-bipolar-and-related-disorders-d4de3f2e.html",
    "scrapedAt": "2025-11-29T18:35:52.736Z"
  },
  "questions": [
    {
      "id": 15738,
      "choices": [
        {
          "id": 62912,
          "text": "<p>Bipolar Type 1 Disorder</p>"
        },
        {
          "id": 62913,
          "text": "<p>Bipolar Type 2 Disorder</p>"
        },
        {
          "id": 62914,
          "text": "<p>Cyclothymia</p>"
        },
        {
          "id": 62915,
          "text": "<p>Recurrent Depressive Disorder</p>"
        }
      ],
      "text": "<p>A 28-year-old male presents to a psychiatrist with a history of excessive happiness, hyper-religiosity, and increased energy for the past 10 days. He reports needing only 4 hours of sleep each night and has been unusually talkative at work. Based on his symptoms, he was diagnosed with a hypomanic episode. Additionally, his medical history reveals three episodes of depression and one episode of mania in the past. What is the diagnosis for this patient?</p>",
      "unique_key": "Q3676976",
      "question_audio": null,
      "question_video": null,
      "map_id": 15445,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. A) Bipolar Type 1 Disorder</strong></p><p><strong>&nbsp;</strong></p><p><strong>Option A.</strong></p><p>&nbsp;</p><p>Bipolar Type 1 Disorder is diagnosed when a patient experiences at least one manic episode, which may be preceded or followed by hypomanic or major depressive episodes. In this case, the patient has experienced one manic episode and three depressive episodes in the past, in addition to the current hypomanic episode. Therefore, the likely diagnosis is Bipolar Type 1 Disorder.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B</strong>. Bipolar Type 2 Disorder is characterized by the presence of at least one hypomanic episode and at least one major depressive episode, without any manic episodes. The patient's history of one manic episode excludes the diagnosis of Bipolar Type 2 Disorder.</p><p>&nbsp;</p><p><strong>Option C</strong>. Cyclothymia is a chronic mood disorder characterized by hypomanic and depressive symptoms that do not meet the criteria for a hypomanic episode or major depressive episode. The symptoms must be present for at least two years.. The presence of a manic episode and major depressive episodes in this patient's history rules out a diagnosis of cyclothymia.</p><p>&nbsp;</p><p><strong>Option D</strong>. Recurrent Depressive Disorder is characterized by recurrent episodes of major depression without any history of mania or hypomania. The patient's history of a manic episode and hypomanic episode excludes the diagnosis of Recurrent Depressive Disorder.&nbsp;</p><p>&nbsp;</p><p><strong>Educational Objective:&nbsp;</strong></p><p>&nbsp;</p><p>A single manic/mixed episode is enough to make the diagnosis of Bipolar type I disorder. The patient in the case has a history of one manic episode, which is sufficient for a diagnosis of Bipolar Type I Disorder, regardless of the current hypomanic episode or the past depressive episodes</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition, Page No 366-368.</span></p>",
      "correct_choice_id": 62912,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15739,
      "choices": [
        {
          "id": 62916,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium plus risperidone</span></span></span></span></span></p>"
        },
        {
          "id": 62917,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Valproate</span></span></span></span></span></p>"
        },
        {
          "id": 62918,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium plus lorazepam</span></span></span></span></span></p>"
        },
        {
          "id": 62919,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Valproate plus lorazepam</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 35-year-old female presents to the emergency department with a 1-week history of severe manic symptoms. She has been experiencing agitation, pressured speech, making big claims, decreased need for sleep, and significant overactivity. Her family reports that she has a history of similar episodes in the past, which have resulted in significant impairment. She has no known history of depressive episodes. Which is the best treatment option for this patient?</span></span></span></p>",
      "unique_key": "Q9301979",
      "question_audio": null,
      "question_video": null,
      "map_id": 15446,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A) Lithium plus risperidone</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">For a patient presenting with <strong>severe manic symptoms</strong>, especially with <strong>agitation and significant overactivity,</strong> a combination of a <strong>mood stabilizer and an antipsychotic</strong> is <strong>often recommended</strong> to manage both the manic symptoms and agitation effectively.&nbsp;</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is a <strong>well-established mood stabilizer</strong> used in the <strong>treatment of bipolar disorder</strong>, particularly <strong>effective in managing manic episodes</strong>. It helps to <strong>stabilize mood</strong> and reduce the severity and frequency of manic episodes. <strong>Risperidone</strong> is an <strong>atypical antipsychotic</strong> that can be <strong>effective in managing acute manic symptoms</strong>, including <strong>agitation and psychosis</strong>, if present.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This combination <strong>(A. Lithium plus risperidone)</strong> allows for <strong>both rapid control of acute manic symptoms</strong> through the <strong>antipsychotic</strong> (risperidone) and <strong>longer-term mood stabilization</strong> with <strong>lithium</strong>.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Valproate&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is also a <strong>mood stabilizer</strong> that can be <strong>used as monotherapy in the management of manic episodes</strong>. While it can be effective, the addition of an antipsychotic like risperidone might be more beneficial for rapid control of severe symptoms.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Lithium plus lorazepam&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">could be considered, <strong>as lorazepam</strong> (a benzodiazepine) <strong>can help manage acute agitation</strong>. However, for <strong>severe manic symptoms</strong>, the addition of an <strong>antipsychotic</strong> (like risperidone) is often preferred for more effective management of the broader range of manic symptoms.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Valproate plus lorazepam&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is another <strong>potential combination</strong>, <strong>with valproate as the mood stabilizer</strong> and <strong>lorazepam for agitation</strong>. However, for severe manic symptoms, especially with psychotic features, the addition of an antipsychotic may be more appropriate.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In the <strong>management of severe manic episodes</strong>, especially with <strong>significant agitation</strong>, <strong>a combination of a mood stabilizer</strong> (such as lithium) and <strong>an antipsychotic</strong> (such as risperidone) is <strong>often the most effective treatment approach</strong>. This combination addresses both the acute symptoms and the need for longer-term mood stabilization.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:</span></span></span></u></strong><strong> </strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 373.</span></span></span></strong></span></span></p>",
      "correct_choice_id": 62916,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15740,
      "choices": [
        {
          "id": 62920,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lamotrigine</span></span></span></span></span></p>"
        },
        {
          "id": 62921,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium plus risperidone</span></span></span></span></span></p>"
        },
        {
          "id": 62922,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Fluoxetine</span></span></span></span></span></p>"
        },
        {
          "id": 62923,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium plus fluoxetine</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 29-year-old female presents to the clinic with a 2-month history of sadness, loss of interest in work, excessive tiredness, negative thoughts, and insomnia. She experienced a similar episode 3 years ago and an episode characterized by over talkativeness, increased energy levels, decreased sleep, and making big plans 5 years ago. The patient is currently not on any medications. What is the appropriate treatment for this patient?</span></span></span></p>",
      "unique_key": "Q2558218",
      "question_audio": null,
      "question_video": null,
      "map_id": 15447,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A) Lamotrigine</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lamotrigine&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is an <strong>appropriate choice for this patient</strong>. According to the <strong>American Psychiatric Association</strong> (APA) <strong>guidelines</strong>, the <strong>first-line pharmacological treatment</strong> for <strong>bipolar depression</strong> is the <strong>initiation of either lithium or lamotrigine</strong>.&nbsp;</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Lithium plus risperidone&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">would be <strong>more appropriate for managing acute manic or mixed episodes</strong>, rather than a depressive episode, as the patient is currently experiencing.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Fluoxetine</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, an SSRI antidepressant, is generally <strong>not recommended as a first-line treatment for bipolar depression</strong>, as it may induce manic or mixed episodes in patients with bipolar disorder when used without a mood stabilizer.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Lithium plus fluoxetine</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, and other <strong>combinations of lithium and antidepressants, can be used in patients with bipolar depression</strong>, but they are not the first choice, as the use of antidepressants may increase the risk of inducing a manic episode or rapid cycling.&nbsp;</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The following are first line treatments for acute depression in a patient with bipolar disorder-</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Mood stabilisers (Lithium, lamotrigine). According to American Psychiatric Association (APA) guidelines, the first-line pharmacological treatment is the initiation of either lithium or lamotrigine.&nbsp;</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Olanzapine + Fluoxetine</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Quetiapine</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A combination of mood stabilisers + antidepressants, can also be used, but in general&nbsp;</span></span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">antidepressants are avoided in a patient with bipolar disorder to avoid the risk of &lsquo;manic switch&rsquo;</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><u>Ref</u>:</span></span></span></strong><strong> </strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 373.</span></span></span></strong></span></span></p>",
      "correct_choice_id": 62920,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15741,
      "choices": [
        {
          "id": 62924,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 1, 2, and 3 are correct.</span></span></span></span></span></p>"
        },
        {
          "id": 62925,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 1, 2, and 4 are correct.</span></span></span></span></span></p>"
        },
        {
          "id": 62926,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 1 and 4 are correct.</span></span></span></span></span></p>"
        },
        {
          "id": 62927,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 2 and 4 are correct.</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 42-year-old male with a history of bipolar disorder presents for a follow-up appointment. The psychiatrist is considering adjusting his mood stabilizer regimen. Which of the following statements are correct regarding the use of mood stabilizers in patients with bipolar disorders?</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium is preferred over valproate for euphoric mania.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Valproate is preferred over lithium for the management of dysphoric mania.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium is preferred over valproate in patients with rapid cycling bipolar disorder.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Valproate is preferred over lithium in patients with rapid cycling.</span></span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q1988560",
      "question_audio": null,
      "question_video": null,
      "map_id": 15448,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B) Statements 1, 2, and 4 are correct.</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">1. Lithium is preferred over valproate for euphoric mania:&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This statement is generally <strong>correct</strong>. Lithium has been traditionally preferred for classic presentations of mania, which often include euphoria. It is effective in managing euphoric mania and is also beneficial for long-term prophylaxis against manic episodes.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:black\"><strong>2. Valproate is preferred over lithium for the management of dysphoric mania:</strong>&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Dysphoric mania</strong>, which includes <strong>symptoms of depression along with mania</strong>, can be more challenging to treat. Valproate is often preferred in these cases due to its efficacy in managing mixed states and dysphoric mania.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:black\"><strong>4. Valproate is preferred over lithium in patients with rapid cycling:</strong>&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Rapid cycling</strong>, defined as <strong>having four or more mood episodes in a year</strong>, can be particularly difficult to manage in bipolar disorder. Valproate is often considered more effective than lithium for patients with rapid cycling bipolar disorder.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">3. The statement that <strong>&quot;Lithium is preferred over valproate in patients with rapid cycling bipolar disorder&quot;</strong> is <strong>incorrect,</strong> which is why it is not included in the correct option. Valproate, not lithium, is generally preferred for rapid cycling due to its potentially greater efficacy in these cases.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In the <strong>treatment of bipolar disorder</strong>, <strong>lithium</strong> is traditionally preferred for <strong>classic euphoric mania and long-term prophylaxis</strong>, while <strong>valproate is often chosen for dysphoric mania</strong>, <strong>mixed states</strong>, and <strong>rapid cycling bipolar disorder</strong> due to its efficacy in these more complex presentations.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:</span></span></span></u></strong><strong> </strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 373.</span></span></span></strong></span></span></p>",
      "correct_choice_id": 62925,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15742,
      "choices": [
        {
          "id": 62928,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Olanzapine</span></span></span></span></span></p>"
        },
        {
          "id": 62929,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium</span></span></span></span></span></p>"
        },
        {
          "id": 62930,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Valproate</span></span></span></span></span></p>"
        },
        {
          "id": 62931,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Psychotherapy</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 28-year-old G2P1 pregnant female at 10 weeks of gestation presents with a two-week history of irritability and racing thoughts. She has been sleeping for only 2 hours per night. Recently, she got into a physical altercation with a colleague and threw her laptop at him. She has been working excessively, insisting that she wants to prove she is the &quot;bestest employee&quot; in the office. Her husband mentions that she has a history of similar episodes in the past but had been stable without medication for the past year. There is no history of substance abuse. What is the most appropriate intervention for this patient?</span></span></span></p>",
      "unique_key": "Q4696699",
      "question_audio": null,
      "question_video": null,
      "map_id": 15449,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A) Olanzapine</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">This patient presents with symptoms suggestive of a <strong><u>manic episode during pregnancy</u></strong>. The symptoms include <strong>irritability, aggression</strong> (throwing laptop), <strong>racing thoughts, decreased need for sleep</strong> (sleeping for only 2 hours), and <strong>grandiose ideas</strong> (bestest employee). <strong>Olanzapine</strong> is an <strong>atypical antipsychotic</strong> used to <strong>treat manic episodes</strong>. It is considered relatively safe during pregnancy and is effective in managing the symptoms presented by the patient. Please remember that antipsychotics are preferred over mood stabilizers for managing mania in pregnant patients.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Lithium&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is the <strong>prototype mood stabilizer</strong>; however, its use <strong>during pregnancy carries a risk of congenital malformations</strong>, particularly <strong>Ebstein&#39;s anomaly</strong>, and therefore is not the preferred choice.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Valproate</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, another <strong>mood stabilizer</strong>, is <strong>not recommended during pregnancy</strong> due to its <strong>association with an increased risk of neural tube defects</strong> and other <strong>congenital malformations</strong>. Valproate must be avoided in pregnancy due to the high risk of neural tube defects.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Psychotherapy&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">alone may <strong>not be sufficient to manage an acute manic episode in this patient</strong>, and a pharmacological intervention is necessary to stabilize her symptoms.&nbsp;</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">In <strong>managing acute manic episodes during pregnancy</strong>, especially in the <strong>first trimester, atypical antipsychotics</strong> like <strong>olanzapine</strong> may be considered due to their relatively <strong>safer profile compared to other options such as lithium and valproate</strong>. <strong>Valproate</strong> is generally <strong>contraindicated due to high risk of neural tube defects</strong>, and lithium requires careful risk-benefit analysis due to its association with congenital cardiac anomalies such as Ebstein&rsquo;s anomaly, VSD etc.&nbsp;</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:</span></span></span></u></strong><strong> </strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 373.</span></span></span></strong></span></span></p>",
      "correct_choice_id": 62928,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15743,
      "choices": [
        {
          "id": 62932,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Postpartum blues</span></span></span></span></span></p>"
        },
        {
          "id": 62933,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Postpartum depression</span></span></span></span></span></p>"
        },
        {
          "id": 62934,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Postpartum psychosis</span></span></span></span></span></p>"
        },
        {
          "id": 62935,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Adjustment disorder with depressed mood</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 31-year-old female presents to her primary care physician for a follow-up appointment 2 weeks after giving birth to a healthy baby. She reports experiencing persistent sadness, loss of interest in her usual activities, difficulty sleeping, low energy, feelings of worthlessness, and difficulty concentrating since the delivery. She also reveals having recurrent thoughts of suicide. What is the most likely diagnosis for this patient?</span></span></span></span></span></p>",
      "unique_key": "Q9754738",
      "question_audio": null,
      "question_video": null,
      "map_id": 15450,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. B) Postpartum depression</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The patient&#39;s symptoms, including <strong>persistent sadness, loss of interest in activities</strong>, <strong>difficulty sleeping, low energy, feelings of worthlessness</strong>, <strong>difficulty concentrating, and suicidal thoughts</strong>, are consistent with <strong>postpartum depression</strong>. <strong>Postpartum depression</strong> is characterized by a <strong>major depressive episode</strong> that occurs within four weeks following delivery, although symptoms may develop later.&nbsp;</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Postpartum blues&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">typically occur within the <strong>first few days following delivery and resolve within two weeks</strong>. Symptoms are mild and may include mood swings, sadness of mood,&nbsp; irritability, and tearfulness. The severity and duration of symptoms in this patient make postpartum blues an unlikely diagnosis.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Postpartum psychosis&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is a <strong>rare and severe psychiatric condition that usually occurs within the first week after delivery</strong>. It is characterized by a rapid onset of symptoms, such as delusions, hallucinations, disorganized behaviour, and severe mood disturbances. The patient&#39;s symptoms do not include these features, making postpartum psychosis an unlikely diagnosis.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Adjustment disorder with depressed mood&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">involves the <strong>development of depressive symptoms</strong> in response to a <strong>specific stressor, such as childbirth</strong>. However, the severity of the patient&#39;s symptoms, including suicidal thoughts, suggests a more significant mood disturbance than would be expected in an adjustment disorder. The appropriate diagnosis in this case is postpartum depression.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Many students make the mistake of choosing the answer solely on the basis of the onset of symptoms in relation to the delivery. This is a wrong approach; the answer must be chosen primarily on the basis of symptoms. E.g. In this question, the history of suicidal thoughts was given so that the answer goes more towards postpartum depression and postpartum blues and adjustment disorder could be ruled out.&nbsp;</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Postpartum depression&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is <strong>seen in 10-15% of females post-delivery</strong>. <strong>Symptom onset is within 3 months of delivery</strong>. Symptoms include sadness, tearfulness, lability, sleep disturbances, anhedonia, suicidal thoughts/thoughts of harming baby, guilt. <strong>Treatment includes pharmacotherapy and psychotherapy</strong>, and it is <strong>treated along the lines of depression</strong>. Newer agents such as <strong>Zuranolon</strong>e and <strong>Brexenolone</strong> (intravenous infusion) are approved specifically for PPD. Brexanolone is similar to endogenous allopregnanolone, which is a hormone that decreases after childbirth.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><u>Ref</u>:&nbsp;</span></span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 626-627.</span></span></span></strong></span></span></p>",
      "correct_choice_id": 62933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15744,
      "choices": [
        {
          "id": 62936,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Postpartum blues</span></span></span></span></span></p>"
        },
        {
          "id": 62937,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Postpartum depression</span></span></span></span></span></p>"
        },
        {
          "id": 62938,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Postpartum psychosis</span></span></span></span></span></p>"
        },
        {
          "id": 62939,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Adjustment disorder with depressed mood</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 31-year-old female presents to the emergency department accompanied by her husband 3 days after giving birth to a healthy baby. She reports experiencing persistent sadness, difficulty sleeping, and extreme irritability. Her partner shares concerns about her unusual behaviour, such as claiming that the baby is in danger and there are forces trying to kill the baby and hearing voices telling her to harm the baby. What is the most likely diagnosis for this patient?</span></span></span></span></span></p>",
      "unique_key": "Q8452652",
      "question_audio": null,
      "question_video": null,
      "map_id": 15451,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. C) Postpartum psychosis</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Postpartum psychosis&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is a <strong>rare and severe psychiatric condition</strong> that <strong>usually occurs within the first week after delivery</strong>. It is <strong>characterized by a rapid onset of symptoms</strong>, such as <strong>delusions, hallucinations, disorganized behaviour, and severe mood disturbances</strong>. The patient&#39;s symptoms, including delusion of persecution and auditory hallucinations, are consistent with postpartum psychosis.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Postpartum blues&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">typically occur within the <strong>first few days following delivery and resolve within two weeks</strong>. Symptoms are mild and may include mood swings, sadness of mood, irritability, and tearfulness. Although the patient is experiencing some of these symptoms, the presence of delusion of persecution and auditory hallucinations suggests a more severe condition than postpartum blues.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Postpartum depression&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is characterized by a <strong>major depressive episode that occurs within four weeks following delivery</strong>, although <strong>symptoms may develop later</strong>. The patient&#39;s symptoms include persistent sadness, difficulty sleeping, and irritability, which could be consistent with postpartum depression. However, the presence of delusion of persecution and auditory hallucinations indicates a more severe psychiatric condition, making postpartum depression an unlikely diagnosis.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Adjustment disorder with depressed mood&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">involves the <strong>development of depressive symptoms in response to a specific stressor</strong>, such as <strong>childbirth</strong>. However, the severity and nature of the patient&#39;s symptoms, including delusion of persecution and auditory hallucinations, suggest a more significant psychiatric disturbance than would be expected in an adjustment disorder. The appropriate diagnosis in this case is postpartum psychosis.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Postpartum psychosis&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is usually <strong>seen within 2-3 weeks of delivery</strong>. Initial symptoms include tearfulness, insomnia, and lability. <strong>Later delusions</strong> (e.g. baby is dead, didn&rsquo;t give birth to a child) and <strong>hallucinations develop</strong>. There is a <strong>risk of harm to self or the baby</strong>. In some cases, the baby has to be separated from the mother to prevent harm to the baby. Treatment includes the use of antipsychotics with lithium; antidepressants may be added if required.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><u>Ref</u>:&nbsp;</span></span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Textbook of Women&rsquo;s Reproductive Mental Health, 1st edition, Page No 434-435.</span></span></span></strong></span></span></p>",
      "correct_choice_id": 62938,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15745,
      "choices": [
        {
          "id": 62940,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 1 and 3 are correct.</span></span></span></span></span></p>"
        },
        {
          "id": 62941,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 2 and 4 are correct.</span></span></span></span></span></p>"
        },
        {
          "id": 62942,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 1 and 4 are correct.</span></span></span></span></span></p>"
        },
        {
          "id": 62943,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 2 and 3 are correct.</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 28-year-old pregnant woman with a history of bipolar disorder presents to her psychiatrist for a medication review. The psychiatrist discusses the risks and benefits of different mood stabilizers during pregnancy. Which of the following statements about the use of mood stabilizers during pregnancy are correct?</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Valproate can cause neural tube defects (NTDs), however, the incidence of NTDs on valproate is much lesser than the incidence of Ebstein&#39;s anomaly on lithium.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium can cause Ebstein&#39;s anomaly, but the incidence of the same is lesser than that of NTDs on valproate.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Antipsychotics are preferred over both lithium and valproate due to less teratogenicity.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Antipsychotics should not be preferred over lithium and valproate as they can cause extrapyramidal side effects.</span></span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q6196187",
      "question_audio": null,
      "question_video": null,
      "map_id": 15452,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. D) Statements 2 and 3 are correct.</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">2. This statement is correct</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong>Lithium can cause Ebstein&#39;s anomaly</strong>, a rare congenital heart defect, but the incidence is lower than that of NTDs on valproate.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">3. This statement is also correct</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. In many cases, <strong>antipsychotics may be preferred over lithium and valproate during pregnancy</strong> due to their <strong>lower teratogenic risk</strong>. However, the choice of medication depends on the individual patient&#39;s clinical presentation, the severity of her symptoms, and her response to previous treatments.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">1<strong>. Valproate can indeed cause neural tube defects (NTDs)</strong>, but this statement is <strong>incorrect</strong> because the incidence of NTDs on valproate is actually higher than the incidence of Ebstein&#39;s anomaly on lithium.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">4. This statement is incorrect.&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">While antipsychotics can cause extrapyramidal side effects, they are generally considered to have a lower teratogenic risk than lithium and valproate. The decision to use antipsychotics during pregnancy should be based on a careful consideration of the risks and benefits for each patient.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pregnancy and mood stabilizers</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">:</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium can cause congenital cardiac anomalies which include Ebstein&rsquo;s anomaly, ASD and VSD.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Valproate can cause neural tube defects (NTD).</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">But the incidence of NTDs with valproate is higher compared to that of cardiac anomalies with lithium.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">But compared to both, antipsychotics are safer in pregnancy. Hence they are preferred over both lithium and valproate.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:</span></span></span></u></strong><strong> </strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 653, 657.</span></span></span></strong></span></span></p>",
      "correct_choice_id": 62943,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15746,
      "choices": [
        {
          "id": 62944,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 1 and 3 are correct.</span></span></span></span></span></p>"
        },
        {
          "id": 62945,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 2, 3, and 4 are correct.</span></span></span></span></span></p>"
        },
        {
          "id": 62946,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 1, 3, and 4 are correct.</span></span></span></span></span></p>"
        },
        {
          "id": 62947,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Statements 1 and 4 are correct.</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Regarding physician suicide, which of the following statements are correct?</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Female physicians have a higher suicide rate than male physicians.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Male physicians have a higher suicide rate than female physicians.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Psychiatrists and anesthesiologists have a higher suicide rate in comparison to other specialties.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The suicide rate in physicians is lesser in comparison to the general population as they are more aware of mental illnesses.</span></span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q5121379",
      "question_audio": null,
      "question_video": null,
      "map_id": 15453,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A) Statements 1 and 3 are correct.</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">1. This statement is <strong>correct</strong>. <strong>Female physicians have been found to have a higher suicide rate than male physicians.</strong> Studies have reported that female physicians are 2.27 times more likely to die by suicide than the general population.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">3. This statement is <strong>correct</strong>. Some studies have suggested that <strong>psychiatrists and anesthesiologists may have a higher suicide rate</strong> in comparison to other medical specialties.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">2. This statement is <strong>incorrect</strong>. As mentioned above, female physicians have a higher suicide rate than male physicians.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">4. This statement is <strong>incorrect</strong>. Despite being more aware of mental illnesses, physicians have a higher suicide rate than the general population. A number of factors contribute to this higher rate, including the stress and demands of the profession, stigma surrounding mental health issues, and access to lethal means.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Among physicians</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, <strong>female physicians have a higher suicide rate compared to male physicians</strong>, contrasting with the general population trend. Certain specialties, such as <strong>psychiatry and anesthesiology,</strong> are associated with <strong>higher suicide rates</strong>. Overall, physicians do not have a lower suicide rate compared to the general population, despite their greater awareness of mental health issues.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:</span></span></span></u></strong><strong> </strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#374151\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 812.</span></span></span></strong></span></span></p>",
      "correct_choice_id": 62944,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15747,
      "choices": [
        {
          "id": 62948,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium toxicity</span></span></span></span></span></p>"
        },
        {
          "id": 62949,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Neuroleptic malignant syndrome</span></span></span></span></span></p>"
        },
        {
          "id": 62950,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Serotonin syndrome</span></span></span></span></span></p>"
        },
        {
          "id": 62951,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Malignant hyperthermia</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 38-year-old patient with bipolar disorder has been on a combination of lithium, haloperidol, and fluoxetine for the last 2 years and has been maintaining well. The patient decided to fast for 9 days for religious reasons. On the 6th day of the fast, the patient developed nausea, abdominal pain, and tremors. He was taken to the hospital where he could not speak properly and also had difficulty walking. What is the likely diagnosis?</span></span></span></p>",
      "unique_key": "Q9382294",
      "question_audio": null,
      "question_video": null,
      "map_id": 15454,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A) Lithium toxicity</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:</span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Lithium toxicity&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is the most likely diagnosis in this case. The <strong>patient&#39;s decision to fast may have led to dehydration</strong>, which in <strong>turn could have increased lithium levels</strong> in the <strong>body due to reduced renal clearance</strong>. The symptoms of nausea, abdominal pain, tremors, difficulty speaking (suggestive of dysarthria), and difficulty walking (suggestive of ataxia) are all consistent with lithium toxicity.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B. Neuroleptic malignant syndrome (NMS)&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is a <strong>rare but serious side effect of antipsychotic medications such as haloperidol</strong>. However, the patient&#39;s symptoms do not fit the classic presentation of NMS, which typically includes severe muscle rigidity, fever, and autonomic instability. Additionally, the patient has been on haloperidol for 2 years without any issues, making NMS less likely.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Serotonin syndrome&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is a <strong>potentially life-threatening condition caused by excessive serotonin levels</strong>, often due to the <strong>use of serotonergic medications like fluoxetine</strong>. While some of the patient&#39;s symptoms, such as tremors, could be consistent with serotonin syndrome, the overall clinical picture aligns more closely with lithium toxicity.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Malignant hyperthermia&nbsp;</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is a <strong>potentially fatal reaction to certain medications used during general anesthesia.</strong> It is not relevant to this case, as the patient was not exposed to any triggering agents and the symptoms do not match the typical presentation of malignant hyperthermia.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational objective: </span></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Risk factors for Lithium toxicity include</span></span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">:</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Low dietary intake</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Dehydration (secondary to fasting, diarrhea etc)</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Use of thiazide diuretics, ACE inhibitors, NSAIDs etc.</span></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Addison&rsquo;s disease.</span></span></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Signs and symptoms of Lithium toxicity:</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/11/screenshot-2024-03-11-170955.jpg\" style=\"height:436px; width:1000px\" /></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><u>Ref</u>:&nbsp;</span></span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 253.</span></span></span></strong></span></span></p>",
      "correct_choice_id": 62948,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38063,
      "choices": [
        {
          "id": 152015,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It has a lifetime prevalence of approximately 1%.</span></span></span></span></p>"
        },
        {
          "id": 152016,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The average age of onset is 21 years.</span></span></span></span></p>"
        },
        {
          "id": 152017,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is more prevalent in males than in females.</span></span></span></span></p>"
        },
        {
          "id": 152018,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Divorced and single individuals have a higher incidence of bipolar disorder.</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dr. Priyanka Sen, a psychiatrist in Kolkata, was leading a case discussion with her residents about a 24-year-old woman named Mira. Mira had presented with episodes of elevated mood, increased energy, and decreased need for sleep alternating with periods of profound sadness and lethargy. After a detailed evaluation, a diagnosis of bipolar disorder was considered. To test her residents&#39; knowledge, Dr. Sen posed a question: &quot;Which of the following statements regarding bipolar disorder, in light of our discussions, is incorrect?&quot;</span></span></p>",
      "unique_key": "Q1588385",
      "question_audio": null,
      "question_video": null,
      "map_id": 23760,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) It is more prevalent in males than in females.</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The statement that <strong>bipolar disorder is more prevalent in males than in females is incorrect</strong>. While <strong>bipolar 1 disorder</strong> has equal prevalence, <strong>bipolar 2 disorder has female preponderance</strong>. But given the options&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: It has a lifetime prevalence of approximately 1%:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>correct.</strong> Bipolar disorder is a relatively common mental health condition with a lifetime prevalence of around 1% in the general population.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: The average age of onset is 21 years:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is also <strong>correct.</strong> The average age of onset for bipolar disorder is typically in the late teens to early twenties. Mean age of onset of bipolar 1 disorder is 18 years and that of bipolar 2 disorder is mid 20s.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Divorced and single individuals have a higher incidence of bipolar disorder:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>true</strong>. Marital status, particularly being divorced or single, has been associated with a higher incidence of bipolar disorder, potentially due to the stressors and life changes associated with these statuses.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>lifetime prevalence</strong> of <strong>bipolar disorder is 1%.</strong> The prevalence of <strong>bipolar I disorder is quite similar in men and women with a lifetime male-to-female prevalence ratio being 1.1:1</strong>. Manic episodes are more common in men and depressive episodes are more common in women. The mean age of onset for bipolar I is around 18 years and bipolar II is in mid 20s. It is more commonly seen in divorced and single persons.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 376.</strong></span></span></span></span></p>",
      "correct_choice_id": 152017,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38064,
      "choices": [
        {
          "id": 152019,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">14 days.</span></p>"
        },
        {
          "id": 152020,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">4 days.</span></p>"
        },
        {
          "id": 152021,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">7 days.</span></p>"
        },
        {
          "id": 152022,
          "text": "<p><span style=\"font-size:12.0pt;\">10 days.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the minimum duration, according to ICD-11, required for establishing a diagnosis of mania?</span></p>",
      "unique_key": "Q6419006",
      "question_audio": null,
      "question_video": null,
      "map_id": 23761,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C) 7 days.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">According to the <strong>ICD-11</strong>, the <strong>minimum duration required for establishing a diagnosis of mania is 7 days</strong>. This <strong>criterion is set to differentiate mania</strong> from <strong>shorter periods of elevated mood</strong> that may not meet the <strong>clinical threshold for a diagnosis of a manic episode</strong> such as <strong>hypomania.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A: 14 days:&nbsp;</strong>This <strong>duration is longer than the minimum required</strong> by ICD-11 for a manic episode.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B: 4 days:&nbsp;</strong>This <strong>duration is for the diagnosis of hypomania</strong>, which is a less severe form of mania.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D: 10 days:&nbsp;</strong>This <strong>duration, like 14 days, exceeds the minimum required duration</strong> specified in the ICD-11.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">According to the <strong>ICD-11, a manic episode should be present for a minimum of 7 days</strong> (or any duration if hospitalization is necessary) for a <strong>diagnosis of mania to be established</strong>. This <strong>helps differentiate a manic episode</strong> from a <strong>hypomanic episode</strong> which lasts at <strong>least 4 days</strong> and <strong>lacks the severity to cause marked impairment in social or occupational functioning</strong> or necessitate hospitalization.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref</u>:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>International Classification of Diseases, 11th edition, Page No 23</strong>.</span></p>",
      "correct_choice_id": 152021,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38065,
      "choices": [
        {
          "id": 152023,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosome 5.</span></span></span></span></p>"
        },
        {
          "id": 152024,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosome 18.</span></span></span></span></p>"
        },
        {
          "id": 152025,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosome 21.</span></span></span></span></p>"
        },
        {
          "id": 152026,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromosome 22.</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 31-year-old man presents to the psychiatric clinic with a history of mood swings that have been impacting his personal and professional life. He describes periods where he feels &quot;on top of the world,&quot; talks rapidly, engages in impulsive behaviors, and gets by on minimal sleep. These episodes alternate with periods where he feels profoundly depressed loses interest in daily activities, and contemplates self-harm. His sister was diagnosed with a similar condition a few years ago. Intrigued by the familial pattern, the psychiatrist orders a genetic workup.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recent studies have linked bipolar disorder to multiple genomic regions. Which of the following chromosomes has been LEAST closely associated with the genetic predisposition to bipolar disorder?</span></span></span></span></p>",
      "unique_key": "Q1229609",
      "question_audio": null,
      "question_video": null,
      "map_id": 23762,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Chromosome 5.</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While several chromosomes have been implicated in bipolar disorder, the prominence of association varies. Among the options provided, <strong>chromosome 5 has a weaker established connection with bipolar disorder compared to some of the other chromosomes</strong> mentioned.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There&#39;s <strong>evidence to suggest a genetic linkage to bipolar disorder</strong> on chromosomes B) <strong>18</strong>, C) <strong>21</strong> and D) <strong>22</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/11/screenshot-2024-03-11-172014.jpg\" style=\"height:297px; width:800px\" /></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 11th edition, Page No 353</strong>.</span></span></span></span></p>",
      "correct_choice_id": 152023,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38066,
      "choices": [
        {
          "id": 152027,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypersomnia&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152028,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insomnia</span></span></span></span></p>"
        },
        {
          "id": 152029,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced need for sleep&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152030,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased sleep latency&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which sleep characteristic is typically seen in mania?&nbsp;</span></span></p>",
      "unique_key": "Q5142986",
      "question_audio": null,
      "question_video": null,
      "map_id": 23763,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Reduced need for sleep</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mania is a distinct period&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of <strong>abnormally and persistently elevated, expansive, or irritable mood</strong>. <strong>Sleep disturbances</strong> are characteristic <strong>features of mania,</strong> with the most common manifestation being a reduced need for sleep.&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Hypersomnia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>excessive sleepiness and is not characteristic of mania</strong>. It might be seen in other conditions like atypical depression or narcolepsy.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Insomnia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>individuals with mania might experience difficulty sleeping</strong>, the key feature of <strong>mania is the reduced <em>need</em> for sleep.</strong> They feel energized despite not getting adequate rest.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Decreased sleep latency:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This refers to the <strong>amount of time it takes to transition from full wakefulness to sleep</strong>. It&#39;s not the primary sleep disturbance seen in mania.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with mania display&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">characteristic<strong> sleep patterns</strong> i.e., <strong>decreased need for sleep.</strong> Patients in a <strong>manic episode might feel rested after only a few hours of sleep</strong> or even after <strong>no sleep at all</strong>. This reduced need for sleep differentiate mania from conditions where there might be insomnia (i.e., difficulty falling or staying asleep) but with a continued desire or need for sleep.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 365-366.</strong></span></span></span></span></p>",
      "correct_choice_id": 152029,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38067,
      "choices": [
        {
          "id": 152031,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Depression</span></span></span></span></p>"
        },
        {
          "id": 152032,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizophrenia</span></span></span></span></p>"
        },
        {
          "id": 152033,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mania</span></span></span></span></p>"
        },
        {
          "id": 152034,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Grief reaction</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old woman presents to the outpatient clinic accompanied by her adult children. They report that nine months after the sudden death of her husband, she began demonstrating a stark change in her behavior. They noticed that she has been attending religious gatherings every day, sometimes multiple times a day. She has donated significant sums of money to various organizations, leaving her finances in jeopardy. She frequently talks about a newfound purpose to bring transformative change to society. Her children add that she rarely sleeps, often staying awake through the night and involved in various activities. Upon examination, she appears well-groomed but agitated. She expresses frustration at being brought to the clinic, insisting that there&#39;s nothing wrong. Her speech is pressured, and she frequently goes off on tangents. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q8294557",
      "question_audio": null,
      "question_video": null,
      "map_id": 23764,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Mania</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient&#39;s presentation, including <strong>symptoms like markedly increased activity or energy</strong>, <strong>excessive involvement in activities</strong> that have a <strong>high potential for painful consequences</strong> (e.g., unrestrained spending sprees), <strong>decreased need for sleep</strong>, <strong>more talkative than usual</strong>, flight of ideas or subjective experience that thoughts are racing, and distractibility, <strong>align with the criteria for mania</strong>.&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Depression:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with depression <strong>display a depressed mood, loss of interest in activities, fatigue, feelings of worthlessness or guilt, impaired concentration</strong>, and often <strong>thoughts of death or suicide</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Schizophrenia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>characterized by the presence of delusions, hallucinations, disorganized speech, and negative symptoms</strong> like <strong>flattened affect</strong>, <strong>anhedonia, and decreased speech</strong>. The clinical picture as described in this scenario is more consistent with mania.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Grief reaction:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Grief is a <strong>natural response to the loss of a loved one</strong>. <strong>Normal grief</strong> can share some <strong>symptoms with depression, such as intense sadness, insomnia, and loss of interest or pleasure in usual activities.</strong> However, the excessive energy, grandiosity, and other symptoms in this scenario point towards mania than a typical grief reaction.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/11/screenshot-2024-03-11-173137.jpg\" style=\"height:490px; width:1000px\" /></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 365.</strong></span></span></span></span></p>",
      "correct_choice_id": 152033,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38068,
      "choices": [
        {
          "id": 152035,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adjustment disorder with depressed mood</span></span></span></span></p>"
        },
        {
          "id": 152036,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Major depression</span></span></span></span></p>"
        },
        {
          "id": 152037,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premenstrual dysphoric disorder</span></span></span></span></p>"
        },
        {
          "id": 152038,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysthymic disorder</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 21-year-old woman visits a psychiatrist, reporting cyclic episodes of intense anger and irritability that she experiences on average every month. During these episodes, she describes overwhelming feelings of anxiety, an inner sensation of being on the verge of bursting, rapid mood shifts between tearfulness and episodes of rage, and significant difficulty concentrating. She also mentions increased sleep during these periods. The intensity of her symptoms is such that she often misses several days of classes as she feels unable to cope. Based on her symptoms and their cyclical nature, which of the following is the most probable diagnosis?&nbsp;</span></span></span></span></p>",
      "unique_key": "Q1520187",
      "question_audio": null,
      "question_video": null,
      "map_id": 23765,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Premenstrual dysphoric disorder</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation of severe mood swings, anger, irritability, anxiety, crying spells, sleep disturbances, and functional impairment that occur monthly and are presumably related to her menstrual cycle are characteristic of premenstrual dysphoric disorder (PMDD).</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Adjustment disorder with depressed mood:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adjustment disorders are <strong>reactions to identifiable stressors that cause emotional or behavioral symptoms</strong> within <strong>3 months of the stressor.</strong> Symptoms would not have a cyclic pattern as described here.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Major depression:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While some <strong>symptoms of major depression overlap with PMDD, major depression does not have a cyclic pattern</strong> that correlates with the menstrual cycle.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Dysthymic disorder:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysthymic disorder is <strong>characterized by chronic low-grade depressive symptoms</strong> that last for at <strong>least two years</strong>. It would not present with monthly cyclic symptoms as described in the scenario.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premenstrual dysphoric disorder&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(PMDD) is a <strong>new diagnosis in DSM-5 and ICD-11</strong>. It is a <strong>severe form of premenstrual syndrome</strong> (PMS). or <strong>absent in the week post menses</strong>. The symptoms include <strong>irritability, mood lability, depressive mood, anxiety symptoms.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Somatic symptoms like lethargy, edema, breast tenderness, weight gain, sleep &amp; appetite changes can also be seen. The symptoms cause significant socio-occupational dysfunction. Treatment is symptomatic, involves the use of analgesics, diuretics, SSRIs and benzodiazepines.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 628</strong>.</span></span></span></span></p>",
      "correct_choice_id": 152037,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38069,
      "choices": [
        {
          "id": 152039,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postpartum blues</span></span></span></span></p>"
        },
        {
          "id": 152040,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postpartum depression</span></span></span></span></p>"
        },
        {
          "id": 152041,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postpartum anxiety</span></span></span></span></p>"
        },
        {
          "id": 152042,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postpartum psychosis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman, who recently had a normal vaginal delivery 3 days ago, is came to the clinic with complaints of mood swings, tearfulness, and feelings of overwhelm. She reports that these feelings are transient and fluctuate throughout the day. She is otherwise bonding well with her newborn. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q1996683",
      "question_audio": null,
      "question_video": null,
      "map_id": 23766,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Postpartum blues</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>patient&#39;s presentation</strong> is consistent with <strong>postpartum blues, a common and mild form of postpartum mood disturbance.</strong>&nbsp; Postpartum blues typically occur within the <strong>first few days after delivery and resolve spontaneously within two weeks</strong>. Symptoms can include mood swings, irritability, anxiety, sadness, and crying episodes. These symptoms are generally mild and do not require medical treatment.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postpartum depression is <u>more severe and persistent</u> than postpartum blues</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, with symptoms lasting beyond two weeks and potentially interfering with the mother&#39;s ability to care for herself or her baby.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Postpartum anxiety could present with symptoms of anxiety</strong>, but the patient&#39;s presentation of crying and feeling low is more indicative of postpartum blues or depression.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Postpartum psychosis is a rare and severe condition that typically presents within the first two to three weeks postpartum.</strong> Symptoms can include hallucinations, delusions, and disorganized thinking. This is a psychiatric emergency and requires immediate medical attention.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postpartum blues&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(baby blues) is seen in <strong>30-75% of females after childbirth</strong>. It is characterized by <strong>transient symptoms like tearfulness, sadness, mood lability and sleep disturbances</strong>&nbsp;(basically mild depressive symptoms). <strong>Onset</strong> is usually within <strong>3-5 days of delivery</strong>. Symptoms last for days to weeks. Support to mother is enough for resolution of symptoms.&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Textbook of Women&rsquo;s Reproductive Mental Health, 1st edition, Page No 383.</strong></span></span></span></span></p>",
      "correct_choice_id": 152039,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38070,
      "choices": [
        {
          "id": 152043,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Major depressive disorder.</span></span></span></span></p>"
        },
        {
          "id": 152044,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bipolar disorder type I.</span></span></span></span></p>"
        },
        {
          "id": 152045,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bipolar disorder type II.</span></span></span></span></p>"
        },
        {
          "id": 152046,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Borderline personality disorder.</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman presents to her primary care physician with a history of mood swings and depression. She reports periods of feeling extremely energetic, happy, and confident, during which she doesn&#39;t need much sleep and becomes highly productive. These episodes last for about 4-5 days and are followed by depressive episodes characterized by sadness, loss of interest in her usual activities, and fatigue that can persist for several weeks. She denies any psychotic symptoms during these episodes. The patient&#39;s medical history is otherwise unremarkable, and there is no family history of psychiatric illnesses. Physical examination and routine laboratory tests are within normal limits. Based on her presentation, which of the following is the most likely diagnosis?</span></span></span></span></p>",
      "unique_key": "Q9135824",
      "question_audio": null,
      "question_video": null,
      "map_id": 23767,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Bipolar disorder type II.</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation is suggestive of <strong>Bipolar Disorder Type II</strong>. This diagnosis is characterized by a <strong>pattern of <u>depressive episodes</u></strong> and <strong><u>hypomanic episodes</u></strong>. The <strong>description of her having periods of elevated mood, increased energy, and reduced need for sleep lasting 4-5 days</strong> (hypomanic episodes), alternating with periods of significant <strong>depressive symptoms lasting several weeks</strong>, aligns with <strong>Bipolar II Disorder</strong>. Importantly, in Bipolar II Disorder, the patient does not experience full manic episodes.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Major Depressive Disorder:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While the patient experiences depressive episodes, the <strong><u>presence of hypomanic episodes excludes a diagnosis of Major Depressive Disorder</u></strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Bipolar Disorder Type I:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This disorder is characterized by at least one manic episode, which may be preceded or followed by hypomanic or major depressive episodes. <strong><u>The patient does not describe any full manic episodes</u></strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Borderline Personality Disorder:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>mood swings can be a feature of Borderline Personality Disorder</strong>, the specific pattern and duration of mood episodes described by the patient are more consistent with Bipolar Disorder Type II.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bipolar disorder type II&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by <strong>hypomanic and major depressive episodes</strong>. The presence of <strong>mania rules out the diagnosis of Bipolar disorder type II</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><u><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></strong></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 368-369.</span></span></strong></span></span></p>",
      "correct_choice_id": 152045,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38071,
      "choices": [
        {
          "id": 152047,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Rapid onset of depression&nbsp;&nbsp;</span></p>"
        },
        {
          "id": 152048,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Psychotic symptoms&nbsp;</span></p>"
        },
        {
          "id": 152049,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Mood lability&nbsp;</span></p>"
        },
        {
          "id": 152050,
          "text": "<p><span style=\"font-size:12.0pt;\">Psychomotor agitation</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">You are consulted regarding a 14-year-old boy who has recently been displaying symptoms of depression. His school teacher reports that he appeared to become sad suddenly over a week, often seeming distant and preoccupied. His mother shares that he has moments where he claims to hear voices telling him he's worthless. On some days, he shifts rapidly between bouts of crying and periods of irritability. During the clinic visit, you observe that he frequently fidgets, can't sit still, and displays signs of restlessness. Given this presentation, which of the following features in this child's depressive episode is least indicative of a future risk of developing bipolar disorder?</span></p>",
      "unique_key": "Q4321373",
      "question_audio": null,
      "question_video": null,
      "map_id": 23768,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D) Psychomotor agitation</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Among the features listed in the child's presentation, <strong>psychomotor agitation is the least indicative of a future risk of developing bipolar disorder.</strong> Psychomotor agitation, which includes symptoms like <strong>restlessness and fidgeting</strong>, can be a <strong>feature of depression</strong> and is not specifically indicative of bipolar disorder.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Rapid onset of depression:&nbsp;</strong>A sudden or <strong>rapid onset of depressive symptoms</strong> can be <strong>indicative of bipolar disorder</strong>, as mood episodes in bipolar disorder often have a more acute onset compared to unipolar depression.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B. Psychotic symptoms:&nbsp;</strong>The presence of psychotic symptoms, such as <strong>auditory hallucinations, during a depressive episode can suggest a higher likelihood of bipolar disorder</strong>. In pediatric cases, psychotic symptoms in depression warrant a careful assessment for bipolarity.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C. Mood lability:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Rapid shifts in mood</strong>, such as quickly <strong>going from sadness to irritability,</strong> are suggestive of <strong>bipolarity and an increased risk of bipolar disorder.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/11/screenshot-2024-03-11-174605.jpg\" alt=\"\" width=\"1000\" height=\"545\"></u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ref:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition, Page No 385.</strong></span></p>",
      "correct_choice_id": 152050,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38072,
      "choices": [
        {
          "id": 152051,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mania&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152052,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schizoaffective disorder in mania</span></span></span></span></p>"
        },
        {
          "id": 152053,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypomania&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152054,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclothymia</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 16-year-old female patient presents to the clinic with an array of concerning behaviours observed over the past week. Her parents report that she has been unusually overly friendly, even with strangers, and she has been speaking rapidly and jumping from topic to topic in a way that is hard to follow. They have also noticed an unusually elevated mood and an increase in her expression of sexual desires. They are unsure of how to handle these changes and are seeking help. Based on the clinical findings, what is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q8165276",
      "question_audio": null,
      "question_video": null,
      "map_id": 23769,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Mania</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this scenario, the <strong>patient&#39;s overfamiliarity, flight of ideas, elevated mood,</strong> and <strong>increased sexual desire</strong> all point towards a <strong>manic episode</strong>. Mania is characterized by <strong>elevated or irritable mood</strong>, <strong>increased energy or activity</strong>, and other symptoms such as inflated self-esteem, decreased need for sleep, and distractibility.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Schizoaffective disorder in mania:</strong> While the <strong>patient exhibits features of mania</strong>, there is <strong>no mention of symptoms characteristic of schizophrenia</strong>, such as delusions or hallucinations, which are necessary for a diagnosis of schizoaffective disorder.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Hypomania:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypomania is <strong>similar to mania but less severe</strong>; it does not cause significant impairment in social or occupational functioning. The behaviors described seem too extreme for hypomania.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Cyclothymia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a <strong>chronic mood disorder characterized by numerous periods of hypomanic symptoms</strong> and <strong>periods of depressive symptoms</strong> lasting for at <strong>least 2 years</strong>. The symptoms are not severe enough to meet the criteria for a hypomanic episode and a major depressive episode.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation described is <strong>indicative of a manic episode</strong>, characterized by an <strong>abnormally elevated mood</strong>, <strong>increased sociability</strong>, <strong>rapid and disorganized speech</strong>, and <strong>increased sexual desires</strong>. These symptoms are more severe than those seen in hypomania or cyclothymia and lack the psychotic features required for schizoaffective disorder.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 365.</strong></span></span></span></span></p>",
      "correct_choice_id": 152051,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38073,
      "choices": [
        {
          "id": 152055,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">There is at least one episode of mania</span></p>"
        },
        {
          "id": 152056,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The duration criterion for diagnosis is 2 years</span></p>"
        },
        {
          "id": 152057,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">There is at least one episode of depression</span></p>"
        },
        {
          "id": 152058,
          "text": "<p><span style=\"font-size:12.0pt;\">There is at least one episode of hypomania</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 25-year-old female presents to the psychiatric clinic with a history of fluctuating mood patterns. She reports experiencing periods of elevated energy, increased creativity, and decreased need for sleep, but these episodes are not severe enough to cause marked impairment in social or occupational functioning. Additionally, she experiences periods of low mood, fatigue, and decreased interest in activities, but these episodes do not meet the full criteria for a major depressive episode. These mood fluctuations have been present for the past 3 years, with no symptom-free period lasting longer than 2 months. Based on her clinical presentation, which of the following statements is correct about her condition?</span></p>",
      "unique_key": "Q6469280",
      "question_audio": null,
      "question_video": null,
      "map_id": 23770,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B) The duration criterion for diagnosis is 2 years</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The clinical presentation of the 25-year-old female with <strong>fluctuating mood patterns that include periods of elevated energy, creativity, and decreased need for sleep</strong> (which are not severe enough to cause marked impairment) along with <strong>periods of low mood and fatigue</strong>, is indicative of <strong>Cyclothymic Disorder</strong>. <strong>Cyclothymic Disorder</strong> is characterized by <strong>chronic, fluctuating mood disturbances involving numerous periods of hypomanic symptoms</strong> and periods of depressive symptoms that <strong>do not meet</strong> the criteria for a <strong>major depressive episode</strong>. The key point in this diagnosis is the chronic nature of the condition, with the symptoms persisting for at least 2 years in adults (or 1 year in children and adolescents), without any symptom-free period extending longer than 2 months.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A: There is at least one episode of mania:&nbsp;</strong>Mania is <strong>not present in Cyclothymic Disorder</strong>. If a manic episode occurs, the diagnosis would change to Bipolar I Disorder.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C: There is at least one episode of depression:&nbsp;</strong>The depressive symptoms in Cyclothymic Disorder <strong>do not meet the full criteria for a major depressive episode</strong>.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D: There is at least one episode of hypomania:&nbsp;</strong>In Cyclothymic Disorder, while symptoms resembling <strong>hypomania are present</strong>, they may not always be sufficiently severe or prolonged to meet the full criteria for a hypomanic episode. Therefore, the presence of a <strong>hypomanic episode is not an absolute criterion for diagnosing cyclothymia.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Cyclothymia&nbsp;</strong>is a <strong>milder form of bipolar disorder</strong>, in which <strong>manic symptoms and depressive symptoms occur</strong>, but they are never severe enough to make a diagnosis of mania or depression. The <strong>symptoms should last for at least 2 years</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ref:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition, Page No 369.</strong></span></p>",
      "correct_choice_id": 152056,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38074,
      "choices": [
        {
          "id": 152059,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbamazepine&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152060,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoclopramide&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152061,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NSAIDs&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152062,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Haloperidol</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with a known diagnosis of bipolar disorder has been on lithium maintenance therapy for several years. During her recent routine check-up, her serum lithium level was found to be significantly elevated compared to her previous levels. She mentioned starting a new medication a few weeks ago. Which of the following medications could explain the rise in her lithium level?</span></span></p>",
      "unique_key": "Q2372377",
      "question_audio": null,
      "question_video": null,
      "map_id": 23771,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) NSAIDs</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nonsteroidal anti-inflammatory drugs&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NSAIDs) can lead to an <strong>increase in serum lithium levels</strong>. This <strong>interaction occurs because NSAIDs reduce the renal clearance of lithium</strong>, leading to <strong>elevated levels in the blood</strong>. Patients on lithium therapy are typically advised to use NSAIDs cautiously or opt for alternative pain relievers to avoid this interaction.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Carbamazepine:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It <strong>does not typically cause an increase in lithium levels</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Metoclopramide:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This medication, used <strong>primarily for nausea and gastroparesis,</strong> does not have a significant <strong>interaction with lithium in terms of altering lithium levels</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Haloperidol:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It <strong>does not typically affect lithium levels significantly.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs which increase the levels of Lithium include:&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACE inhibitors</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiazide diuretics</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NSAIDs</span></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 254.</span></span></strong></span></span></p>",
      "correct_choice_id": 152061,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38075,
      "choices": [
        {
          "id": 152063,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T3RU&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152064,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TSH&nbsp;</span></span></p>"
        },
        {
          "id": 152065,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total bilirubin&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152066,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CBC</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old male with a history of mood fluctuations has been recently initiated on lithium therapy for his bipolar disorder. Given the known systemic effects of this medication, his psychiatrist emphasizes the importance of periodic laboratory monitoring. Which of the following blood tests should be prioritized for consistent biannual assessment due to its potential alteration by lithium?</span></span></p>",
      "unique_key": "Q1824285",
      "question_audio": null,
      "question_video": null,
      "map_id": 23772,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) TSH</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When a patient is on lithium therapy, <strong>periodic monitoring of thyroid function</strong>, particularly <strong>thyroid-stimulating hormone</strong> (TSH), is important due to <strong>lithium&#39;s potential impact on thyroid function</strong>. <strong>Lithium</strong> can cause <strong>hypothyroidism</strong> by <strong>interfering with thyroid hormone synthesis and release</strong>. Consequently, monitoring TSH levels biannually is a crucial aspect of managing patients on long-term lithium therapy.&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: T3RU (Triiodothyronine Resin Uptake):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is <strong>not the primary test chosen to monitor lithium</strong>-associated thyroid dysfunction.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Total bilirubin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium<strong> does not generally have significant effects on liver function tests</strong> like bilirubin.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: CBC (Complete Blood Count):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>lithium can cause leukocytosis</strong>, CBC is not included in the biannual tests conducted during treatment.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pre-treatment tests&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">with <strong>Lithium include serum creatinine, TSH, ECG and pregnancy test</strong> (in females). On treatment <strong>monitoring includes serum Lithium levels, serum creatinine, and TSH every 6 months.</strong>&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 251.</span></span></strong></span></span></p>",
      "correct_choice_id": 152064,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38076,
      "choices": [
        {
          "id": 152067,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administration of normal saline IV&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152068,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emergency dialysis&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152069,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administration of benztropine IM&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152070,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac monitoring</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23-year-old male, with a known history of bipolar disorder, is brought into the emergency department by his roommate who found him unconscious next to an empty bottle of lithium pills. On examination, the patient is lethargic and responding minimally to painful stimuli. His vitals reveal mild bradycardia, and initial labs show a lithium level of 4.5 meq/L. Additionally, his urine output is markedly diminished, registering at about 15 mL/hr. Given these findings, what is the most immediate therapeutic intervention necessary for this patient?</span></span></p>",
      "unique_key": "Q2820260",
      "question_audio": null,
      "question_video": null,
      "map_id": 23773,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Emergency dialysis</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient has <strong>severe lithium toxicity,</strong> evidenced by his <strong>high serum lithium level</strong> (4.5 meq/L) and <strong>neurological and renal impairment.</strong> <strong>Emergency dialysis</strong> is vital in <strong>cases of high lithium concentrations</strong> combined with <strong>acute kidney injury</strong> and significant neurological symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Administration of normal saline IV&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is beneficial for <strong>mild to moderate lithium toxicity</strong>, but inadequate for this severity.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Administration of benztropine IM</strong> is for <strong>extrapyramidal symptoms from antipsychotics</strong>, not relevant here.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac monitoring&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is essential in <strong>overdose scenarios but isn&#39;t the primary intervention</strong> needed given the lithium toxicity and renal impairment.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Signs and symptoms of Lithium toxicity:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/11/screenshot-2024-03-11-181248.jpg\" style=\"height:477px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 250-251.</strong></span></span></span></span></p>",
      "correct_choice_id": 152068,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38077,
      "choices": [
        {
          "id": 152071,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Less than 24 hours&nbsp;</span></p>"
        },
        {
          "id": 152072,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">4 days&nbsp;</span></p>"
        },
        {
          "id": 152073,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">5 days&nbsp;</span></p>"
        },
        {
          "id": 152074,
          "text": "<p><span style=\"font-size:12.0pt;\">2 to 3 weeks</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 27-year-old woman, previously diagnosed with bipolar disorder, is admitted due to an acute manic phase. She exhibits elation, rapid speech with frequent topic shifts, and claims she's the \"next Virgin Mary\" chosen by God. Initial blood tests including BUN, creatinine, electrolytes, and TSH, as well as an ECG, are all normal. After conducting the necessary evaluations, the decision is made to initiate her on lithium therapy. How long, with consistent dosing, will it take for the medication to reach a steady state in her system?</span></p>",
      "unique_key": "Q6969115",
      "question_audio": null,
      "question_video": null,
      "map_id": 23774,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans C) 5 days</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Lithium reaches a steady state in the body after about 5 half-lives</strong>. The <strong>half-life of lithium</strong> is <strong>approximately 24 hours</strong> in most <strong>adults</strong>, depending on <strong>kidney function</strong>. Therefore, with regular administration, it generally takes about:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">1 half-life = 24 hours</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>5 half-lives = 5 x 24 = 120 hours or 5 days for lithium to reach steady state</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Less than 24 hours</strong> is <strong>too short for lithium</strong> to reach a steady state.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>4 days is close</strong>, but slightly <strong>less than the standard time</strong> for lithium to reach its steady state.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D.</strong>&nbsp;<strong>2 to 3 weeks is a longer duration</strong> than required for lithium to reach a steady state.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Half-life of Lithium is 24 hours.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Lithium reaches a steady state</strong> in the body <strong>after approximately 5 days</strong> (or 5 half-lives) with regular administration. Hence serum lithium levels are obtained 5 days after initiation or dose adjustment of lithium. Lithium is excreted in urine (99%).&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>:&nbsp;Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition, Page No 649</strong>.</span></p>",
      "correct_choice_id": 152073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38078,
      "choices": [
        {
          "id": 152075,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After 8 hours of the last dose</span></span></span></span></p>"
        },
        {
          "id": 152076,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After 12 hours of the last dose</span></span></span></span></p>"
        },
        {
          "id": 152077,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">After 24 hours of the last dose</span></span></span></span></p>"
        },
        {
          "id": 152078,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Immediately after the last dose</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old female with a longstanding history of bipolar disorder has been recently stabilized on lithium therapy. Her manic episodes have decreased significantly in frequency and intensity, and she reports feeling more balanced. As her treating physician, you are aware of the importance of monitoring her lithium levels to ensure they are within the therapeutic range and to prevent toxicity. Today, she has come for a routine follow-up, and you plan to check her serum lithium level to ensure it is within the therapeutic range. When would be the most appropriate time to ask the nurse to obtain a blood sample for serum lithium levels?</span></span></p>",
      "unique_key": "Q2876334",
      "question_audio": null,
      "question_video": null,
      "map_id": 23775,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) After 12 hours of the last dose</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium has a narrow therapeutic index</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, meaning that the <strong>therapeutic dose and toxic dose are very close to each other</strong>. Therefore, it is <strong>crucial to monitor serum lithium levels to prevent toxicity</strong>. It also helps use in <strong>acheiving effective lithium dosage</strong>. Serum lithium levels should be drawn 12 hours after the last dose, right before the next dose, to ensure that you are measuring the trough level. This helps in assessing the steady-state concentration of the drug, providing the most accurate reflection of the lithium concentration that the patient is maintaining.&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>After 8 hours of the last dose</strong> would <strong>not</strong> provide an <strong>accurate measure of the trough level</strong>, as the drug may not have reached its steady-state concentration in the blood.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>After 24 hours</strong> of the <strong>last dose would be too long to wait</strong>, as it would be time for the next dose and could potentially lead to subtherapeutic levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Immediately after the last dose</strong> would <strong>measure peak levels</strong>, which <strong>does not accurately reflect the steady-state concentration</strong> that the patient is maintaining and could lead to misinterpretation and potential mismanagement of the patient&rsquo;s condition.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monitoring of serum lithium levels&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">should be <strong>done after 12 hours of the last dose</strong>. So if the patient took the lithium at 9 pm at night, the blood sample should be taken at 9 am in the morning to measure the serum lithium levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 249.</strong></span></span></span></span></p>",
      "correct_choice_id": 152076,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38089,
      "choices": [
        {
          "id": 152119,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Ventricular septal defect&nbsp;&nbsp;</span></p>"
        },
        {
          "id": 152120,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Cleft palate&nbsp;&nbsp;</span></p>"
        },
        {
          "id": 152121,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Neural tube defects&nbsp;&nbsp;</span></p>"
        },
        {
          "id": 152122,
          "text": "<p><span style=\"font-size:12.0pt;\">Ebstein's anomaly</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 24-year-old woman, currently 8 weeks pregnant, visits her obstetrician for her first prenatal appointment. During the review of her medical history, it is discovered that she has been taking lithium for the management of bipolar disorder. She's concerned about the effects of the medication on her developing baby. A focused ultrasound is performed. Which of the following anomalies is the baby at highest risk for due to the mother's lithium use?</span></p>",
      "unique_key": "Q2594988",
      "question_audio": null,
      "question_video": null,
      "map_id": 23785,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. D) Ebstein's anomaly</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Lithium use during pregnancy</strong>, especially during the <strong>first trimester,</strong> is associated with an <strong>increased risk of Ebstein's anomaly</strong> in the <strong>developing fetus</strong>. <strong>Ebstein's anomaly</strong> is a <strong>rare congenital heart defect</strong> characterized by <strong>abnormal development of the tricuspid valve</strong> and <strong>right ventricle</strong>. While the absolute risk of this condition is still relatively low, it is significantly higher in fetuses exposed to lithium compared to the general population.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A: Ventricular septal defect:&nbsp;</strong>While<strong> ventricular septal defects are common congenital heart defects</strong>, they are not specifically associated with lithium use.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B: Cleft palate:&nbsp;</strong>There is <strong>no specific association between lithium use in pregnancy and the development of cleft palate in the fetus</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C: Neural tube defects:&nbsp;</strong>These are <strong>not specifically linked to lithium use</strong>. The use of valproate during pregnancy is more commonly associated with neural tube defects.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Lithium use during pregnancy</strong>, particularly during the <strong>first trimester</strong>, is <strong>associated with an increased risk of Ebstein's anomaly,</strong> a <strong>rare congenital heart defect</strong>. Hence, <strong>high resolution ultrasound</strong> and <strong>echocardiography</strong> is recommended in <strong>6th and 18th week of pregnancy</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ref:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Kaplan &amp; Sadockâ€™s Synopsis of Psychiatry, 12th edition, Page No 653.</strong></span></p>",
      "correct_choice_id": 152122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38090,
      "choices": [
        {
          "id": 152123,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproate&nbsp;&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152124,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium&nbsp;&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152125,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamotrigine</span></span></span></span></p>"
        },
        {
          "id": 152126,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risperidone</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 21-year-old pregnant woman in her second trimester presents with a week of decreased sleep, intense religious preoccupations, and claims of a &quot;divine mission.&quot; She&#39;s elated, demonstrates flight of ideas, and believes in her elevated status. She has had two prior major depressive episodes. Which medication is typically avoided in pregnancy due to associated risks?</span></span></p>",
      "unique_key": "Q8903290",
      "question_audio": null,
      "question_video": null,
      "map_id": 23786,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Valproate</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproate&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is typically <strong>avoided in pregnancy due to its high teratogenic risks</strong>. Valproate <strong>exposure</strong> during <strong>pregnancy</strong> is associated with a significant risk of <strong><u>neural tube defects</u></strong> (such as spina bifida), <strong>heart defects</strong>, and <strong>craniofacial anomalies.</strong>&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Lithium:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>lithium use during pregnancy can increase the risk of congenital heart defects</strong> (notably, <u>Ebstein&#39;s anomaly</u>), these risks are generally <strong>lower compared to those associated with valproate</strong>. Lithium may be used during pregnancy, but it requires careful monitoring and consideration of the risks and benefits.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Lamotrigine:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamotrigine is <strong>one of the safer options for managing bipolar disorder during pregnancy,</strong> but it still carries some risk, and its use should be closely monitored.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Risperidone:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antipsychotics like risperidone&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are considered the <strong>safest and are preferred over mood stabilisers</strong> for the <strong>management of mania in a pregnant patient</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/11/screenshot-2024-03-11-182434.jpg\" style=\"height:309px; width:1000px\" /></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 692.</strong></span></span></span></span></p>",
      "correct_choice_id": 152123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38091,
      "choices": [
        {
          "id": 152127,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium</span></span></span></span></p>"
        },
        {
          "id": 152128,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olanzapine</span></span></span></span></p>"
        },
        {
          "id": 152129,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproate</span></span></span></span></p>"
        },
        {
          "id": 152130,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olanzapine and fluoxetine</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old man presents with 5-day episodes of elevated mood, reduced sleep, impulsiveness, and excessive spending. They reports that he had experienced around five distinct episodes of mood elevation and depression in the past 12 months. Post these episodes, he has 4-day periods of profound depression, anhedonia, and suicidal thoughts. No substance abuse or significant findings on exams. What is the drug of choice?</span></span></p>",
      "unique_key": "Q1123388",
      "question_audio": null,
      "question_video": null,
      "map_id": 23787,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Valproate</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation is consistent with <strong>rapid-cycling bipolar disorder</strong>, as evidenced by the <strong>occurrence of multiple distinct mood episodes</strong> (both manic and depressive) within a <strong>12-month period</strong>. While several medications can be used to treat bipolar disorder, <strong>valproate is particularly effective in the management of rapid-cycling bipolar disorder</strong>.&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Lithium:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is <strong>effective for classical bipolar disorder</strong> but might be less effective for rapid-cycling forms.&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Olanzapine:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can be <strong>used for manic episodes</strong> in <strong>bipolar disorder</strong> but is <strong>not the first-line treatment</strong> for rapid cycling.&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Olanzapine and fluoxetine combination:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This combination is mainly <strong>indicated for the depressive phase of bipolar disorder</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rapid-cycling bipolar disorder&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by the <strong>occurrence of four or more mood episodes within a 12-month period</strong>. <strong>Valproate is the drug of choice</strong> for rapid-cycling bipolar disorder.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 258; Shah N, Grover S, Rao GP. Clinical Practice Guidelines for Management of Bipolar Disorder. Indian J Psychiatry. 2017 Jan;59(Suppl 1):S51-S66.</span></span></strong></span></span></p>",
      "correct_choice_id": 152129,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38092,
      "choices": [
        {
          "id": 152131,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add risperidone to imipramine&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152132,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop imipramine, start valproate&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152133,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add valproate to imipramine&nbsp;</span></span></span></span></p>"
        },
        {
          "id": 152134,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop imipramine</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient diagnosed with depression began treatment with imipramine. Two weeks into the treatment regimen, noticeable changes in behaviour were observed. The patient demonstrated overtalkativeness, euphoria, overfamiliarity, and insomnia. Based on these recent developments, what should be the next step in managing this patient&rsquo;s condition?</span></span></p>",
      "unique_key": "Q7386592",
      "question_audio": null,
      "question_video": null,
      "map_id": 23788,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Stop imipramine, start valproate</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The development of <strong>symptoms such as overtalkativeness, euphoria, overfamiliarity, and insomnia in a patient recently started on imipramine</strong> is highly suggestive of a <strong>switch into mania.</strong>&nbsp;<u><strong>Immediate discontinuation of the antidepressant is crucial</strong></u>. Given the patient&#39;s manic symptoms, <strong><u>starting a mood stabilizer like valproate</u></strong> is the appropriate next step to manage and stabilize her mood.&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Add risperidone to imipramine:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option addresses the <strong>manic symptoms but does not remove the offending agent</strong>, imipramine, which could exacerbate manic symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Add valproate to imipramine:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This <strong>introduces a mood stabilizer</strong> <strong>but maintains the use of the antidepressant,</strong> which could continue to provoke manic symptoms.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Stop imipramine:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discontinuing&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">the <strong>antidepressant is a necessary step</strong>, but in the context of <strong>acute mania</strong>, it is often insufficient without the concurrent initiation of a mood stabilizer.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with <strong>Bipolar Disorder who experience a manic switch triggered by antidepressants</strong>, the <strong>immediate discontinuation</strong> of the <strong>antidepressant and initiation of a mood stabilizer</strong>/ antipsychotic is the preferred course of <strong>action to stabilize mood and manage manic symptoms.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 389.</strong></span></span></span></span></p>",
      "correct_choice_id": 152132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38093,
      "choices": [
        {
          "id": 152135,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zuranolone</span></span></span></span></p>"
        },
        {
          "id": 152136,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vortioxetine</span></span></span></span></p>"
        },
        {
          "id": 152137,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vilazodone</span></span></span></span></p>"
        },
        {
          "id": 152138,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Agomelatine</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old woman presents to her primary care physician 6 weeks after delivering her first child. She reports feeling persistently sad, overwhelmed, and fatigued. She often cries without reason and feels detached from her baby, describing difficulty bonding. She also mentions difficulty sleeping even when her baby is asleep and has a diminished appetite. The patient denies any thoughts of harming herself or her baby but feels desperate for relief. The physician considers pharmacotherapy. Which of the following is the latest FDA-approved drug specifically for the above condition?</span></span></p>",
      "unique_key": "Q7280991",
      "question_audio": null,
      "question_video": null,
      "map_id": 23789,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Zuranolone</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of the 28-year-old woman is indicative of <strong>postpartum depression</strong>. <strong>Zuranolone</strong> (also known as SAGE-217) is the <strong>latest medication approved by the FDA specifically for the treatment of postpartum depression</strong>. <strong>Zuranolone</strong> is a <strong>neuroactive steroid GABA-A receptor positive allosteric modulator</strong> and represents a new class of antidepressants.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vortioxetine&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>antidepressant approved for the treatment of major depressive disorder</strong> (MDD) that <strong>acts by blocking serotonin reuptake transporters</strong> and <strong>inhibiting 5HT3 and 5HT7 receptors</strong>. While it may be used to treat PPD based on its indication for MDD, it is not specifically approved for PPD.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Vilazodone&nbsp;</strong>is another <strong>antidepressant approved for MDD which&nbsp; acts as a partial agonist at the 5HT1A receptors</strong> along with <strong>inhibition of serotonin reuptake</strong> (hence it is known as SPARI: Serotonin Partial Agonist Reuptake Inhibitor). Like Vortioxetine, it can be used to treat PPD based on its indication for MDD, but it is not specifically approved for PPD.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Agomelatine</strong>: An <strong>antidepressant</strong> that <strong>works as a melatonin receptor agonist</strong> and <strong>5-HT2C antagonist</strong>, used for <strong>major depressive disorder</strong> in some countries, but not specifically for postpartum depression and not the latest for this indication.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postpartum depression is seen in 10-15% of females post delivery</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Symptom onset</strong> is <strong>within 3 months of delivery</strong>. Symptoms include <strong>sadness, tearfulness, lability, sleep disturbances, anhedonia, suicidal thoughts/thoughts of harming baby, guilt</strong>. Treatment includes <strong>pharmacotherapy and psychotherapy</strong> and it is treated along the lines of depression. Newer agents such as Zuranolone and Brexenolone (intravenous infusion) are approved specifically for PPD. Brexanolone is similar to endogenous allopregnanolone, which is a hormone that decreases after childbirth.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 626-627.</span></span></span></span></strong></p>",
      "correct_choice_id": 152135,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38094,
      "choices": [
        {
          "id": 152139,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Euphoric mania</span></span></span></span></p>"
        },
        {
          "id": 152140,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bipolar depression</span></span></span></span></p>"
        },
        {
          "id": 152141,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unipolar depression</span></span></span></span></p>"
        },
        {
          "id": 152142,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysphoric mania</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In which of the following scenarios is lamotrigine most appropriately used as a treatment option?</span></span></p>",
      "unique_key": "Q2228892",
      "question_audio": null,
      "question_video": null,
      "map_id": 23790,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Bipolar depression</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamotrigine&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">has been found to be <strong>particularly effective in treating and preventing the depressive episodes of bipolar disorder</strong>, making this the correct choice.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Euphoric mania:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamotrigine&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is <strong>not the first-line treatment</strong> for <strong>acute manic episodes</strong>. Mood stabilizers like lithium or antipsychotic medications are more commonly used.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Unipolar depression:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>lamotrigine</strong> might be <strong>used off-label in some cases of treatment-resistant depression,</strong> it&#39;s not a first-line treatment for unipolar depression.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Dysphoric mania:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>lamotrigine might play a role</strong>, the treatment of these episodes often involves <strong>other mood stabilizers or antipsychotics.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamotrigine&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is an <strong>anticonvulsant mood stabilizer</strong> that is <strong>effective in bipolar depression</strong>. It is the <strong>safest mood stabilizer in pregnancy.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>: Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 659.</span></span></span></span></strong></p>",
      "correct_choice_id": 152140,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38095,
      "choices": [
        {
          "id": 152143,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olanzapine</span></span></span></span></p>"
        },
        {
          "id": 152144,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium</span></span></span></span></p>"
        },
        {
          "id": 152145,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproate</span></span></span></span></p>"
        },
        {
          "id": 152146,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lorazepam</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old pregnant woman at 12 weeks&#39; gestation presents to the outpatient psychiatric clinic accompanied by her husband. He reports that over the last 10 days, she has shown erratic behaviour, characterized by a decreased need for sleep, excessive spending, and speaking rapidly about various grand business ideas. He adds that she also seems easily distracted and has become more socially outgoing to the point of inappropriate interactions with strangers. Her obstetric records indicate an uncomplicated pregnancy so far, and she denies any substance use. Her family history reveals that her mother had been diagnosed with bipolar disorder. Given her current condition and pregnancy status, which medication would be the most appropriate initial treatment for her symptoms?</span></span></p>",
      "unique_key": "Q1075375",
      "question_audio": null,
      "question_video": null,
      "map_id": 23791,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Olanzapine.</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>patient&#39;s symptoms are consistent with a manic episode</strong>. Given her <strong>pregnancy, olanzapine</strong> is relatively <strong>safer during pregnancy</strong> and is <strong>suitable for managing manic symptoms.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Lithium:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It poses a risk of <strong><u>fetal cardiac malformations</u></strong> specifically <strong>Ebstein&rsquo;s anomaly</strong>, especially in the first trimester.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Valproate:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is linked to <strong><u>neural tube defects</u></strong> and is contraindicated in pregnancy.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Lorazepam:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It <strong><u>doesn&#39;t address underlying mania</u></strong> and has potential fetal risks with chronic use such as <strong><u>preterm deliveries</u>.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antipsychotics&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are much <strong>more safer than mood stabilizers</strong>, also effective. If a pregnant female develops a manic episode, choose antipsychotics over mood stabilizers.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><u style=\"font-weight:bold\">Ref</u><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 692.</strong></span></span></span></span></p>",
      "correct_choice_id": 152143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38096,
      "choices": [
        {
          "id": 152147,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Agranulocytosis.</span></p>"
        },
        {
          "id": 152148,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Double vision.</span></p>"
        },
        {
          "id": 152149,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Stevens-Johnson syndrome.</span></p>"
        },
        {
          "id": 152150,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreatitis.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 36-year-old woman with a history of bipolar disorder is seen in the outpatient psychiatric clinic for a medication review. She has been stabilized on carbamazepine for the past year. Now, she inquires about the potential side effects of her medication. Which of the following side effects that she mentions is a dose-dependent adverse effect of carbamazepine, rather than an idiosyncratic one?</span></p>",
      "unique_key": "Q4433347",
      "question_audio": null,
      "question_video": null,
      "map_id": 23792,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B) Double vision.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Carbamazepine&nbsp;</strong>can have <strong>both dose-dependent and idiosyncratic side effects</strong>. <strong>Double vision</strong> (diplopia) is a <strong>dose-dependent side effect of carbamazepine.</strong> This means that the likelihood and severity of this side effect increase with higher doses of the medication.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The other listed <strong>side effects</strong> are considered <strong>idiosyncratic</strong>, meaning they can occur unpredictably and are not necessarily related to the dose:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A. Agranulocytosis:&nbsp;</strong>This is a <strong>rare but serious reduction in white blood cells</strong> that can occur with <strong>carbamazepine use</strong>. It is <strong>not dose-dependent</strong> and requires immediate medical attention if suspected.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C. Stevens-Johnson syndrome:&nbsp;</strong>This is a <strong>severe and potentially life-threatening skin reaction</strong>. This is an idiosyncratic reaction associated with carbamazepine, especially in individuals with the HLA-B*1502 allele.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D. Pancreatitis:&nbsp;</strong>Although a <strong>rare side effect</strong>, <strong>pancreatitis</strong> associated with <strong>carbamazepine</strong> is considered <strong>idiosyncratic and not dose-dependent.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:&nbsp;</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Side effects of Carbamazepine:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/11/screenshot-2024-03-11-184958.jpg\" alt=\"\" width=\"1000\" height=\"389\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ref:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 265-266.</strong>&nbsp;</span></p>",
      "correct_choice_id": 152148,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38097,
      "choices": [
        {
          "id": 152151,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cognitive behavior therapy</span></span></span></span></p>"
        },
        {
          "id": 152152,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cognitive therapy + antidepressant</span></span></span></span></p>"
        },
        {
          "id": 152153,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antidepressant alone</span></span></span></span></p>"
        },
        {
          "id": 152154,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Electroconvulsive therapy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old mother with a 3-month-old child has been diagnosed with mild depression. To ensure the safety of both the mother and the child while effectively managing the depression, which of the following treatment options should be preferred?</span></span></span></span></p>",
      "unique_key": "Q3201575",
      "question_audio": null,
      "question_video": null,
      "map_id": 23793,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Cognitive behavior therapy</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of <strong>mild depression,</strong> especially in <strong>postpartum women</strong>, <strong>non-pharmacological interventions</strong> are often considered <strong>first to avoid potential risks associated with medication exposure</strong> to the <strong>infant through breastfeeding</strong>. <strong>Cognitive behavior therapy</strong> (CBT) <strong>is an evidence-based psychotherapy</strong> that has been shown to be <strong>effective for treating mild to moderate depression</strong>. It is a preferred option for postpartum women as it poses no risk to the breastfeeding infant.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Combining cognitive therapy with an antidepressant:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This might be <strong>considered for more severe cases of depression</strong>, but for mild depression, CBT is preferred over medications.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Antidepressant alone:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It might be <strong>considered in more severe cases or if psychotherapy</strong> <strong>alone is ineffective,</strong> but again, there is the concern of medication exposure to the infant through breastfeeding.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Electroconvulsive therapy (ECT):&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ECT is typically reserved for severe, treatment-resistant depression or when rapid response is required</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, such as in cases of <strong>suicidal ideation</strong>. It is not a first-line treatment for mild depression.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/03/11/screenshot-2024-03-11-185425.jpg\" style=\"height:272px; width:1000px\" /></span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Textbook of Women&rsquo;s Reproductive Mental Health, 1st edition, Page 359</strong>.</span></span></span></span></p>",
      "correct_choice_id": 152151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 38098,
      "choices": [
        {
          "id": 152155,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 3, 4</span></span></span></span></p>"
        },
        {
          "id": 152156,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 3, 5</span></span></span></span></p>"
        },
        {
          "id": 152157,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3, 4, 5</span></span></span></span></p>"
        },
        {
          "id": 152158,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3, 4</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old patient diagnosed with bipolar disorder is currently stable but is looking to discuss long-term management options with her psychiatrist. She has a history of both manic and depressive episodes and is concerned about future relapses. The psychiatrist is considering various mood stabilizers for maintenance therapy. Which of the following mood stabilizers have been approved by FDA in the management of bipolar disorder?&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamotrigine</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gabapentine</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproate</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quetiapine</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topiramate</span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q5217659",
      "question_audio": null,
      "question_video": null,
      "map_id": 23794,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1, 3, 4</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mood stabilizers&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are a <strong>critical component in the management of bipolar disorder</strong>, particularly for <strong>long-term maintenance and prevention of relapses</strong>.&nbsp;</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamotrigine is FDA-approved for the maintenance treatment of bipolar I disorder</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. It is particularly effective in preventing depressive episodes.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gabapentin has not been proven effective as a mood stabilizer in bipolar disorder&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in large randomized controlled trials and is not a first-line treatment.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valproate is approved for the treatment of manic episodes in bipolar disorder</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quetiapine is approved for the treatment of both manic and depressive episodes in bipolar disorder</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, as well as for maintenance therapy.</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topiramate&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">has not shown <strong>consistent benefit as a mood stabilizer in bipolar disorder</strong> in large randomized controlled trials and is not considered a first-line treatment.</span></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamotrigine, valproate, lithium, carbamazepine, olanzapine, and quetiapine are FDA approved mood stabilizers&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">for the management of the bipolar disorder.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>:&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaplan &amp; Sadock&rsquo;s Synopsis of Psychiatry, 12th edition, Page No 373.</span></span></strong></span></span></p>",
      "correct_choice_id": 152155,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 96462,
      "choices": [
        {
          "id": 383988,
          "text": "<p><span style=\"font-size:12.0pt;\">12.4</span></p>"
        },
        {
          "id": 383989,
          "text": "<p><span style=\"font-size:12.0pt;\">12.3</span></p>"
        },
        {
          "id": 383990,
          "text": "<p><span style=\"font-size:12.0pt;\">11.7</span></p>"
        },
        {
          "id": 383991,
          "text": "<p><span style=\"font-size:12.0pt;\">12.8</span></p>"
        }
      ],
      "text": "<p>According to the latest NCRB report for the year 2023, what was the suicide rate in India (per lakh population)?</p>",
      "unique_key": "Q5837620",
      "question_audio": null,
      "question_video": null,
      "map_id": 37280,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><strong>Ans. B. 12.3</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>According to the latest NCRB report for the year 2023, the suicide rate in India was 12.3 per lakh population, showing a slight decrease from 12.4 per lakh in 2022.</p><p>&nbsp;</p><p>The suicide rate in cities (16.2 per lakh) was higher than the all-India average.</p><p>&nbsp;</p><p>The most common method of suicide remained hanging, followed by poisoning.</p><p>&nbsp;</p><p>The overall male-to-female ratio among suicide victims was 72.8: 27.2, indicating that males continue to form the majority of suicide deaths in India.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>As per the latest NCRB report for 2023, Indiaâ€™s suicide rate stood at 12.3 per lakh population, slightly lower than the previous year, with hanging being the most common method and higher suicide rates&nbsp;in&nbsp;urban&nbsp;areas.</p>",
      "correct_choice_id": 383989,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}